PMID: 11910045Mar 23, 2002Paper

The potential of DNA vaccination against tumor-associated antigens for antitumor therapy

Experimental Biology and Medicine
Katharina HauptKlauss Mann

Abstract

Conventional treatment approaches for malignant tumors are highly invasive and sometimes have only a palliative effect. Therefore, there is an increasing demand to develop novel, more efficient treatment options. Increased efforts have been made to apply immunomodulatory strategies in antitumor treatment. In recent years, immunizations with naked plasmid DNA encoding tumor-associated antigens have revealed a number of advantages. By DNA vaccination, antigen-specific cellular as well as humoral immune responses can be generated. The induction of specific immune responses directed against antigens expressed in tumor cells and displayed e.g., by MHC class I complexes can inhibit tumor growth and lead to tumor rejection. The improvement of vaccine efficacy has become a critical goal in the development of DNA vaccination as antitumor therapy. The use of different DNA delivery techniques and coadministration of adjuvants including cytokine genes may influence the pattern of specific immune responses induced. This brief review describes recent developments to optimize DNA vaccination against tumor-associated antigens. The prerequisite for a successful antitumor vaccination is breaking tolerance to tumor-associated antigens, which repr...Continue Reading

References

Sep 1, 1992·Human Molecular Genetics·J A WolffA Jani
Mar 23, 1990·Science·J A WolffP L Felgner
Mar 1, 1991·The Journal of Experimental Medicine·L KoulovaB Dupont
Jan 1, 1991·Annual Review of Immunology·R M Steinman
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R S WilliamsJ C Sanford
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N S YangD McCabe
Jun 1, 1995·Immunological Reviews·F K StevensonR E Hawkins
Aug 1, 1995·Immunity·D M Pardoll, A M Beckerleg
Dec 1, 1994·Vaccine·I Danko, J A Wolff
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·E RazM A Yankauckas
Jul 1, 1994·The Journal of Experimental Medicine·A N Houghton
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson
Feb 1, 1993·Seminars in Cell Biology·A Townsend, J Trowsdale
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·L ChengN S Yang
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·D M KlinmanA M Krieg
Jun 1, 1996·Nature Medicine·A R JonsenA G Motulsky
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·B DoeC M Walker
Jan 1, 1996·Viral Immunology·H C Ertl, Z Q Xiang
Sep 1, 1996·Nature Medicine·A D SyrengelasR Levy
Oct 1, 1996·Nature Medicine·C CondonL D Falo
Oct 1, 1996·The Journal of Experimental Medicine·M CorrH Tighe
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Jun 1, 1997·Vaccine·M A Barry, S A Johnston
Nov 5, 1997·Seminars in Immunology·H L Robinson, C A Torres
Apr 1, 1998·Nature·J Banchereau, R M Steinman
May 19, 1998·Nature Medicine·M A Liu
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M GeisslerJ R Wands
Sep 17, 1998·The Journal of Clinical Investigation·L W WeberA N Houghton

❮ Previous
Next ❯

Citations

Dec 25, 2003·Leukemia & Lymphoma·Lorena Passoni, Carlo Gambacorti-Passerini
Apr 30, 2003·World Journal of Gastroenterology : WJG·Shan QinXiao-Mei He
Sep 3, 2009·Expert Review of Vaccines·Laurel Redding, David B Weiner
Apr 7, 2010·Journal of Biomedicine & Biotechnology·Daniela FiorettiMonica Rinaldi
Feb 25, 2018·Expert Review of Anticancer Therapy·Marcelo Nazário CordeiroAntonio Carlos De Freitas
Sep 1, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Mark B Faries, Donald L Morton
Jun 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Evelyne ZeiraEithan Galun
Apr 4, 2008·Cancer Immunology, Immunotherapy : CII·Benjamin B WilliamsRobert G Ramsay
Jul 21, 2005·Cancer Immunology, Immunotherapy : CII·Min Yu, Olivera J Finn
Oct 12, 2010·Clinical & Developmental Immunology·Joel F AldrichRonald C Kennedy
Mar 31, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Cristina MastiniRoberto Chiarle
Jun 5, 2003·International Journal for Parasitology·Gina Cunto-AmestyThomas Kieber-Emmons
Nov 13, 2004·The Journal of Gene Medicine·Gérald J Prud'homme

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Frontiers in Bioscience : a Journal and Virtual Library
Federica BenvenutiOscar R Burrone
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
S Ferrone, X Wang
Expert Opinion on Biological Therapy
Carolina BergerStanley R Riddell
© 2022 Meta ULC. All rights reserved